Schedule 13G ownership disclosure
Xencor Inc
Common Stock, par value $0.01 per share · CUSIP: 98401F105
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 3,798,627.00 · Class: 5.3%
- BVF I GP LLC
Shares: 3,798,627.00 · Class: 5.3%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 2,787,735.00 · Class: 3.9%
- BVF II GP LLC
Shares: 2,787,735.00 · Class: 3.9%
- Biotechnology Value Trading Fund OS LP
Shares: 439,372.00 · Class: 0.6%
- BVF Partners OS Ltd.
Shares: 439,372.00 · Class: 0.6%
- BVF GP HOLDINGS LLC
Shares: 6,586,362.00 · Class: 9.2%
- BVF PARTNERS L P/IL
Shares: 7,133,720.00 · Class: 9.99%
- BVF INC/IL
Shares: 7,133,720.00 · Class: 9.99%
- LAMPERT MARK N
Shares: 7,133,720.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-26-000477
- Form type
- SCHEDULE 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership